Skip to main content
banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
1.M. Mohamadzadeh, L. Chen, and A. L. Schmaljohn, “How Ebola and Marburg viruses battle the immune system,” Nat. Rev. Immunol. 7, 556567 (2007).
2.C. D. Lytle and J. L. Sagripanti, “Predicted inactivation of viruses of relevance to biodefense by solar radiation,” J. Virol. 79, 1424414252 (2005).
3.R. Corvo, M. Zeverino, S. Vagge, S. Agostinelli, S. Barra, G. Taccini, M. T. Van lint, F. Frassoni, and A. Bacigalupo, “Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant,” Radiother. Oncol. 98, 382386 (2011).
4.A. Gruen, W. Ebell, W. Wlodarczyk, O. Neumann, J. S. Kuehl, C. Stromberger, V. Budach, and S. Marnitz, “Total body irradiation (TBI) using helical tomotherapy in children and young adults undergoing stem cell transplantation,” Radiat. Oncol. 8(92) (8pp.) (2013).
5.N. Sullivan, Z. Y. Yang, and G. J. Nabel, “Ebola virus pathogenesis: Implications for vaccines and therapies,” J. Virol. 77, 97339737 (2003).
6.T. W. Geisbert, H. A. Young, P. B. Jahrling, K. J. Davis, T. Larsen, E. Kagan, and L. E. Hensley, “Pathogenesis of Ebola hemorrhagic fever in primate models: Evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells,” Am. J. Pathol. 163, 23712382 (2003).
7.A. H. Zhuang, A. Liu, T. E. Schultheiss, and J. Y. Wong, “Dosimetric study and verification of total body irradiation using helical tomotherapy and its comparison to extended SSD technique,” Med. Dosim. 35, 243249 (2010).
8.E. Dadachova, S. G. Kitchen, G. Bristol, G. C. Baldwin, E. Revskaya, C. Empig, G. B. Thornton, M. K. Gorny, S. Zolla-Pazner, and A. Casadevall, “Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradication,” PLoS One 7, e31866(9pp.) (2012).
9.X. Qiu, J. Audet, G. Wong, S. Pillet, A. Bello, T. Cabral, J. E. Strong, F. Plummer, C. R. Corbett, J. B. Alimonti, and G. P. Kobinger, “Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies,” Sci. Transl. Med. 4, 138ra181(13pp.) (2012).
10.M. Abdel-Wahab, J.-M. Bourque, Y. Pynda, J. Iżewska, D. Van der Merwe, E. Zubizarreta, and E. Rosenblatt, “Status of radiotherapy in Africa: An International Atomic Energy Agency analysis,” Lancet Oncol. 14(4), e168e175 (2013).
11.G. Delaney, S. Jacob, C. Featherstone, and M. Barton, “The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines,” Cancer 104(6), 11291137 (2005).
12.B. Mckay and P. Loftus, “Ebola virus: Experimental drugs approved for use in fighting outbreak in West Africa,” The Wall Street JournalAugust 13, 2014,
13.N. Sanchez, “Secret serum for Ebola virus likely saved 2 American patients,” NewsMax, August 4, 2014,
14.S. Reardon, “Ebola treatments caught in limbo: Logistics and lack of funds keep experimental drugs and vaccines from being used in Africa outbreak,” Nature 511, 520 (2014).
15.C. Hellerman, “Human trial of experimental Ebola vaccine begins this week,” CNN Health, September 2, 2014,
16.J. Surowiecki, “Ebolanomics,” The New Yorker, August 25, 2014,
17.K. Sepkowitz, “What Ebola on a plane means for the U.S.,” The Daily Beast, August 6, 2014,
18.R. M. Macklis, M. Kalaycio, R. Sobecks, P. Pohlman, S. S. Brown, and B. Bolwell, “Low dose total body irradiation (TBI) in outpatient non-myeloablative bone marrow transplantation,” Int. J. Radiat. Oncol., Biol., Phys. 57, S292 (2003).
19.R. N. Shen, L. Lu, H. E. Kaiser, and H. E. Broxmeyer, “Murine AIDS cured by low dosage total body irradiation,” Adv. Exp. Med. Biol. 407, 451458 (1997).
20.K. Feng, E. Divers, Y. Ma, and J. Li, “Inactivation of a human norovirus surrogate, human norovirus virus-like particles, and vesicular stomatitis virus by gamma irradiation,” Appl. Environ. Microbiol. 77(10), 35073517 (2011).
21.R. H. Mole, “The LD50 for uniform low LET irradiation of man,” Br. J. Radiol. 57(677), 355369 (1984).
22.S. Burdach et al., “High-dose therapy for patients with primary multifocal and early relapsed Ewing’s tumors: Results of two consecutive regimens assessing the role of total-body irradiation,” Int. J. Clin. Oncol. 21(16), 30723078 (2003).
23.M. Schoofs, “The Berlin patient,” New York Times magazine, June 21, 1998,
24.E. C. Hayden, “Hopes of HIV cure in ‘Boston patients’ dashed,” Nature News, December 6, 2013,
25.G. Kohler and C. Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity,” Nature 256, 495497 (1975).
26.A. Casadevall, E. Dadachova, and L. A. Pirofski, “Passive antibody therapy for infectious disease,” Nat. Rev. Microbiol. 2, 695703 (2004).
27.D. Tsukrov and E. Dadachova, “The potential of radioimmunotherapy as a new hope for HIV patients,” Expert Rev. Clin. Immunol. 10(5), 553555 (2014).
28.E. Dadachova and A. Casadevall, “Radioimmunotherapy of infectious diseases,” Semin. Nucl. Med. 39(2), 146153 (2009).
29.World Health Organization, “Ebola virus disease,”
30.J. Levs and J. Wilson, “‘Miraculous day’ as American Ebola patients released,” CNN, August 21, 2014,

Data & Media loading...


Article metrics loading...



There is no abstract available for this article.


Full text loading...


Access Key

  • FFree Content
  • OAOpen Access Content
  • SSubscribed Content
  • TFree Trial Content
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd